Skip to main content
logo
Decoy Therapeutics Inc. (DCOY)
NASDAQ: DCOY · Real-Time Price · USD
3.520
-0.060 (-1.68%)
At close: Aug 17, 2026, 4:00 PM EDT
3.520
0.00 (0.00%)
After-hours: Aug 17, 2026, 4:10 PM EDT

Decoy Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.23----1.84
Revenue Growth
------64.84%
Cost of Revenue
-----8.55
Gross Profit
0.23-----6.71
Selling, General & Admin
4.13.734.965.727.146.1
Research & Development
2.230.370.777.1715.84-
Operating Expenses
6.334.15.7312.8922.986.1
Operating Income
-6.1-4.1-5.73-12.89-22.98-12.81
Interest & Investment Income
0.170.10.160.350.22-
Other Non Operating Income (Expenses)
----0.010.04
EBT Excluding Unusual Items
-5.93-4-5.58-12.54-22.74-12.77
Impairment of Goodwill
-----8.87-
Pretax Income
-14.45-12.52-5.58-12.54-31.61-12.77
Net Income
-14.45-12.52-5.58-12.54-31.61-12.77
Net Income to Common
-14.45-12.52-5.58-12.54-31.61-12.77
Net Income Growth
------
Shares Outstanding (Basic)
000---
Shares Outstanding (Diluted)
000---
Shares Change
319.16%20.93%----
EPS (Basic)
-40.40-129.10-69.54---
EPS (Diluted)
-40.40-129.10-69.54---
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8.37-4.83-4.53-12.85-17.6-10.2
Free Cash Flow Per Share
-23.39-49.78-56.44---
Gross Margin
100.00%-----
Operating Margin
-2679.30%-----696.27%
Profit Margin
-6347.85%-----693.84%
Free Cash Flow Margin
-3675.70%-----554.29%
EBITDA
-6.07-4.09-5.73-12.88-22.97-12.79
D&A For EBITDA
0.020.0100.010.010.02
EBIT
-6.1-4.1-5.73-12.89-22.98-12.81